Close this search box.

2021 Course on targeting mutant HTT therapeutically for clinicians of the movement disorder society (MDS) by Ignacio Munoz-Sanjuan

In this 2021 course, Dr. Ignacio Munoz-Sanjuan, VP of translational biology at CHDI Foundation, speaks to the clinicians and movement disorder residents as part of a course about Huntington’s disease organized by EHDN and MDS. The seminar focuses on our current understanding of HTT biological aspects relevant to the development of therapeutics targeting the cause […]